Stephen Kanovsky

Stephen Kanovsky

Director/Board Member at NEOGENOMICS, INC.

Net worth: 1 M $ as of 2026-09-29

63 year
Health Technology
Consumer Services
Health Services

Profile

Mr. Stephen M.
Kanovsky
is an Independent Director at NeoGenomics, Inc. and a General Counsel-Commercial at GE Healthcare, Inc. He is on the Board of Directors at NeoGenomics, Inc. and NeoGenomics Laboratories, Inc. Mr. Kanovsky was previously employed as an Executive Vice President & General Counsel by Archimedes Pharma Ltd., a Senior Vice President-Legal & Government Affairs by Abraxis BioScience, Inc., and a Principal by Merck Consumer Healthcare Group International.
He received his undergraduate degree from the University of Pennsylvania, a graduate degree from Temple University Beasley School of Law and an MBA from Erivan K.
Haub School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-31 75,421 ( 0.06% ) 1 M $ 2026-09-29

Stephen Kanovsky active positions

CompaniesPositionStart
NEOGENOMICS, INC. Director/Board Member 2017-07-18
Corporate Officer/Principal 2012-08-31
Director/Board Member -

Former positions of Stephen Kanovsky

CompaniesPositionEnd
General Counsel -
Corporate Officer/Principal -
General Counsel -
See the detail of Stephen Kanovsky's experience

Education of Stephen Kanovsky

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

87

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Services

Health Technology

Consumer Services

Consumer Services

  1. Stock Market
  2. Insiders
  3. Stephen Kanovsky